RT Journal Article
SR Electronic
T1 Prevalence of SARS-CoV-2 infection in the Luxembourgish population – the CON-VINCE study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.11.20092916
DO 10.1101/2020.05.11.20092916
A1 Snoeck, Chantal J.
A1 Vaillant, Michel
A1 Abdelrahman, Tamir
A1 Satagopam, Venkata P.
A1 Turner, Jonathan D.
A1 Beaumont, Katy
A1 Gomes, Clarissa P. C.
A1 Fritz, Joëlle V.
A1 Schröder, Valerie E.
A1 Kaysen, Anne
A1 Pavelka, Lukas
A1 Stute, Lara
A1 Meyers, Guilherme Ramos
A1 Pauly, Laure
A1 Hansen, Maxime
A1 Pauly, Claire
A1 Aguayo, Gloria A.
A1 Perquin, Magali
A1 Hanff, Anne-Marie
A1 Ghosh, Soumyabrata
A1 Gantenbein, Manon
A1 Huiart, Laetitia
A1 Ollert, Markus
A1 Krüger, Rejko
A1 on behalf of the CON-VINCE study group
YR 2020
UL http://medrxiv.org/content/early/2020/05/18/2020.05.11.20092916.abstract
AB BACKGROUND The World Health Organization declared the outbreak of coronavirus disease to be a public health emergency of international concern on January 30, 2020. The first SARS-CoV-2 infection was subsequently detected in Luxembourg on February 29, 2020. Representative population-based data, including asymptomatic individuals for assessing the viral spread and immune response was, however, lacking worldwide.METHODS Using a panel-based method, we recruited a representative sample of the Luxembourgish population based on age, gender and residency for testing for SARS-CoV-2 infection and antibody status in order to define prevalence irrespective of clinical symptoms. Participants were contacted via email to fill an online questionnaire before biosampling at local laboratories. Participants provided information related to clinical symptoms, epidemiology, socioeconomic and psychological assessments and underwent biosampling, rRT-PCR testing and serology for SARS-CoV-2.RESULTS A total of 1862 individuals were included for our representative sample of the general Luxembourgish population. We detected an ongoing SARS-CoV-2 infection based on rRT-PCR in 5 participants. h Four of the SARS-CoV-2 infected participants were oligosymptomatic and one was asymptomatic. Overall, 35 participants (1.97%) had developed a positive IgG response, of whom 11 self-reported to have previously received a positive rRT-PCR diagnosis of SARS-CoV-2 infection. Our data indicate a prevalence of 0.3% for active SARS-CoV-2 infection in the Luxembourgish population between 18 and 79 years of age.CONCLUSIONS Luxembourgish residents show a low rate of acute infections after 7 weeks of confinement and present with an antibody profile indicative of a more recent immune response to SARS-CoV-2. All infected individuals were oligo- or asymptomatic. Bi-weekly follow-up visits over the next 2 months will inform about the viral spread by oligo- and asymptomatic carriers and the individual changes in the immune profile.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04379297Funding StatementThe CON-VINCE Study is funded by the Research Fund Luxembourg (FNR; CON-VINCE) and the André Losch Foundation (Luxembourg).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to ethical concerns, supporting data cannot be made openly available.